The NeuroVascular Quality Initiative™ (NVQI™) Launches First Procedure Module: Acute Ischemic Stroke
March 26, 2014 – The Society of NeuroInterventional Surgery (SNIS) and M2S announce the launch of the NeuroVascular Quality Initiative™ (NVQI™), a multi-module registry system designed to track performance and outcomes data across a variety of neurovascular conditions. The launch debuts the Acute Ischemic Stroke (AIS) module, which will be used to track and benchmark clinical performance at the center level and nationally, providing valuable insight into the effectiveness of endovascular interventions and associated devices in treating a condition known to be the nation’s fourth leading cause of death. As of today, NVQI is officially enrolling hospitals and specialists in the AIS module.
As neurointerventional procedures (minimally invasive techniques designed to treat endovascular conditions of the brain and spine), have changed the treatment landscape over the past two decades and offered thousands of patients quality treatment alternatives to traditional medical approaches, NVQI is designed to track the success of these procedures, as well as demonstrate areas for improvement. Specifically, NVQI will collect detailed data on:
- Patient demographics including age, weight/height, and co-morbidities
- Patient history including pre-op medications, pre-stroke status and key time metrics associated to patient arrival and imaging
- Procedure details including treatments and devices used and medications given
- Follow-up including 14 day, 30 day, month and 1 year follow up
NVQI will be governed by the SNIS Patient Safety Organization (SNIS PSO), which oversees the data sharing arrangements and patient safety initiatives conducted within the NVQI. The importance of the PSO structure is that it protects all comparative analyses generated within the PSO from legal discovery in state and federal court. Furthermore, it permits the collection of patient identified data for quality improvement purposes without requiring consent from individual patients or prior approval from an Institutional Review Board.
“By encouraging the collection, aggregation, benchmarking, and analysis of clinical data, NVQI will assist SNIS members in understanding and improving patient outcomes in a safe environment. NVQI will also permit tracking of new devices and device efficacy in a real world setting which is a critical need within this evolving field,” said Peter Rasmussen, MD, Medical Director of SNIS PSO.
Gregory Lange, CEO of M2S, adds, “The NVQI Registry, supported by the M2S PATHWAYS platform, can provide, for the first time, both the breadth and depth of real time clinical data to assist hospitals and quality departments, as well as physicians, improve care for stroke patients.
Looking forward, the SNIS PSO is already planning its next-stage launch of two modules dedicated to cerebral aneurysms and cerebral arteriovenous malformations, scheduled for later this year. Additional considerations for modules include diagnostic angiography and spinal disease.
SNIS PSO has chosen M2S as the technology vendor to host the NVQI. All data will be securely stored within the M2S PATHWAYS quality improvement data platform. M2S specializes in cloud-based quality improvement registries for data collection and reporting, offering several unique features designed to maximize reporting as well as ease of use by specialists enrolled in registries hosted on M2S PATHWAYS.
For more information, please contact Nancy Heatley at firstname.lastname@example.org